Value
5.6/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 3.3 |
| P/S | 1.9 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 5.4 |
| PEG | 10.0 |
| Analyst target | 9.0 |
- ▸Forward P/E: 23.4x
- ▸PEG: 0.41
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rambus is a high-quality semiconductor IP licensor with a Rule of 40 score of 43 and a Piotroski F-Score of 8 out of 9, but the stock trades above analyst consensus targets and faces earnings execution risk after missing estimates in 2 of the last 4 quarters, creating near-term headwinds for new buyers.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
The top 5 customers account for 66% of revenue, creating significant vulnerability if any major licensing relationship is renegotiated, lapses, or migrates to a competing IP architecture. Bear case | Customer concentration falls below 60% over the next 12 months as new licensing agreements with additional chip manufacturers diversify the revenue base. | ↑Improving |
| CounterSemiconductor IP licensing inherently concentrates revenue among a small number of large chip makers; the concentration is a structural feature of the market, not a transient risk. | ||
Rambus missed earnings estimates in 2 of the last 4 quarters with an average surprise of -0.45%, signaling that consensus expectations may be too optimistic relative to the company's ability to grow licensing revenue quarter over quarter. Earnings | EPS surprise turns positive in at least 3 of the next 4 quarters, confirming the miss pattern was temporary rather than a sign of structural revenue growth deceleration. | ↑Improving |
| CounterTwo misses out of four quarters is a mild record in context; the one clear beat was a 6% positive surprise, and the inline quarter reflects a business with low revenue volatility. | ||
Rambus earns 32% net margins with a Rule of 40 score of 43 and a Piotroski F-Score of 8 out of 9, placing it among the best-quality businesses in the semiconductor peer group — a profile that typically commands premium multiples over time. Quality breakdown | Net margins remain above 28% and the Rule of 40 score stays above 40 for the next four quarters as licensing revenue grows with data center semiconductor demand. | →Stable |
| CounterA forward price-to-earnings multiple of 39.3 times already prices in the quality premium, leaving little room for multiple expansion even if fundamentals remain strong. | ||
The stock is trading approximately 11.8% above analyst consensus price targets, meaning buyers at the current price of $143 are paying more than what analysts believe the business is worth today, creating a negative asymmetry ratio. Warnings | Analyst consensus price targets are revised upward to above $165 within 12 months following a catalyst such as a new major licensing agreement or data center memory interface win. | ↑Improving |
| CounterAnalyst targets in semiconductor IP are typically anchored to near-term models; a structural multi-year licensing cycle win could justify a price significantly above current targets even if analysts have not yet revised. | ||
CounterSemiconductor IP licensing inherently concentrates revenue among a small number of large chip makers; the concentration is a structural feature of the market, not a transient risk.
CounterTwo misses out of four quarters is a mild record in context; the one clear beat was a 6% positive surprise, and the inline quarter reflects a business with low revenue volatility.
CounterA forward price-to-earnings multiple of 39.3 times already prices in the quality premium, leaving little room for multiple expansion even if fundamentals remain strong.
CounterAnalyst targets in semiconductor IP are typically anchored to near-term models; a structural multi-year licensing cycle win could justify a price significantly above current targets even if analysts have not yet revised.
| Component | Sub-score |
|---|---|
| P/E | 3.3 |
| P/S | 1.9 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 5.4 |
| PEG | 10.0 |
| Analyst target | 9.0 |
| Component | Sub-score |
|---|---|
| ROE | 6.5 |
| ROA | 8.2 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 5.0 |
| FCF quality | 6.0 |
| Moat | 8.4 |
| Rule of 40 | 8.1 |
| Piotroski F | 10.0 |
| Component | Sub-score |
|---|---|
| Rev growth | 8.1 |
| EPS growth | 10.0 |
| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 2.2 |
| Volume | 3.8 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 6.0 |
| Analyst rating | 7.7 |
| Price target | 9.6 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 5.1 |
| quality rank | 7.4 |
| growth rank | 3.4 |
| Component | Sub-score |
|---|---|
| bollinger | 6.8 |
| support resistance | 7.6 |
| 52w position | 0.5 |
| gap | 5.0 |
| Component | Sub-score |
|---|---|
| short interest | 7.3 |
| days to cover | 9.1 |
| volatility | 0.0 |
| put call | 4.7 |
| implied vol | 2.1 |
| max pain risk | 7.0 |
| beta | 3.8 |
| debt equity | 9.9 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 5.6 |
| earnings timing | 5.0 |
| surprise avg | 4.2 |
| news activity | 8.0 |
Growth is cheap relative to earnings, but the technical setup has not yet produced a breakout above resistance (PEG 0.41, quality 8.2/10, growth 9.1/10).
L4:PATH_C2_GARP_WAIT|ENTRY_STICKY:WITHIN_BANDSetup— — No clear chart pattern; technical signals are mixed
EdgeTemporary headwind — High quality (8.2) with weak momentum (2.1)
SuitabilitySpeculative — Drawdown -48% (>40% off 52w high)
The C-path quality+growth combination triggered the STRONG_BUY_WAIT verdict: quality 8.2 and growth 9.1 both clear their thresholds, with asymmetric R:R of 2.54 supporting the read.
The strongest dimensions are Growth at 9.1, Quality at 8.2, and Sentiment at 7.7; the weakest are Momentum at 2.1, Technical at 5.0, and Risk (lower is worse) at 5.5. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 2.54 and an engine sizing output of STARTER.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifNet margin falls below 25% for 2 consecutive quarters, indicating the high-quality business model is deteriorating under competitive pricing pressure.
Trip ifRevenue from any single customer exceeds 25% of total revenue, representing greater concentration than the current top-5 aggregate risk.
Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters, confirming a sustained pattern of consensus overestimation.
Trip ifPrice rises above $165, more than 15% above the current $143, while analyst targets remain below $155, widening the premium to fair value beyond 10%.